Pfizer and Protalix Make Deal on Gaucher's Treatment

Grab this video:

By copying code you agree to Grab Network's Membership Agreement.
Grab Networks
Grab Networks, Yahoo! Contributor Network
Dec 1, 2009 "Share your voice on Yahoo! websites. Start Here."

Pfizer (PFE) and Protalix (PLX) announced today they made an agreement to develop and market a Gauchers disease treatment. Pfizer will pay $60 million upfront to gain worldwide licensing rights to the drug, although Protalix will maintain rights in its home country of Israel.

Credit: Market News Video
Copyright: Market News Video

Published by Grab Networks

A resource for website publishers who want to embed quality, licensed content on a wide variety of topics.  View profile

To comment, please sign in to your Yahoo! account, or sign up for a new account.